Elutia (ELUT) Earnings Date & Reports

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ELUT is expected to report earnings to fall 11.76% to -15 cents per share on August 12

Q2'26

Est.

$-0.15

Q1'26

Missed

by $0.02

Q4'25

Beat

by $1.60

Q3'25

Missed

by $0.04

Q2'25

Missed

by $0.07

The last earnings report on May 14 showed earnings per share of -17 cents, missing the estimate of -15 cents. With 44.37K shares outstanding, the current market capitalization sits at 44.21M.

View a ticker or compare two or three

Compare

ELUT

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ELUT